KIMBERLY MCGILLICUDDY: Open Payments
NPI 1255840401 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 37 payments from 9 companies in 2025. Trend: 2023 $707 · 2024 $625 · 2025 $472
Food & beverage: $413Education: $59
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $207 |
| Axsome Therapeutics, Inc. | 2 | $77 |
| Corium, LLC | 6 | $46 |
| Alkermes, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: FANAPT, Auvelity, Azstarys, VRAYLAR, LYBALVI, CAPLYTA, ARISTADA, REXULTI.
Industry payments across IN — which companies pay providers there.
